MedPath

Prospective randomized study to determine the clinical outcomes of tissue and mechanical aortic valve replacement in patients aged 55-70yrs.

Not Applicable
Recruiting
Conditions
Aortic valve disease
Cardiovascular - Other cardiovascular diseases
Registration Number
ACTRN12609000303246
Lead Sponsor
PAH Private Practice Trust Fund: Research Support Grant
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
220
Inclusion Criteria

Patients requiring Aortic Valve Replacement in the age group 55-70.

Exclusion Criteria

Non-english speaking
Contraindication to anticoagulation
Renal failure requiring dialysis
Associated procedures (+/- Coranary Artery Bipass Graft (CABG))
Endocarditis
Re-operation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ong term survival: monitored by health care professionals via the telephone, clinic appointments and medical records.[Post operatively and six monthly after surgery until end of follow up (up to 10 years).];Freedom from hospitalisation: monitored by health care professionals via the telephone, clinic appointments and medical records.[Six monthly after surgery until end of follow up (up to 10 years)];Quality of life measures: monitored by health care professionals using the SF-36 questionnaire.[At baseline and six months after surgery]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath